Literature DB >> 21555868

Pneumocyte biomarkers KL-6 and surfactant protein D reflect the distinct findings of high-resolution computed tomography in nonspecific interstitial pneumonia.

Hidenori Ichiyasu1, Kazuya Ichikado, Akihisa Yamashita, Kazuhiro Iyonaga, Osamu Sakamoto, Moritaka Suga, Hirotsugu Kohrogi.   

Abstract

BACKGROUND: Serum levels of pneumocyte biomarkers KL-6 and surfactant protein D (SP-D) are useful diagnostic markers for interstitial lung diseases. However, associations of serum KL-6 and SP-D with radiologic findings in nonspecific interstitial pneumonia (NSIP) remain unclear.
OBJECTIVES: To determine whether serum levels of KL-6 and SP-D reflect fibrotic and/or inflammatory processes in NSIP, we investigated the correlation between high-resolution computed tomography (HRCT) findings and serum KL-6 and SP-D levels.
METHODS: Serum levels of KL-6 and SP-D were measured in 21 patients with biopsy-confirmed NSIP. The radiographic extent of 6 HRCT patterns and total HRCT score, defined as the scored fibrotic index, were assessed. Changes in the levels of serum markers and CT findings during follow-up were also monitored.
RESULTS: Serum levels of KL-6 in NSIP positively correlated with the total HRCT score and overall extent of interstitial disease. Serum levels of SP-D in NSIP showed a positive correlation with the area of ground-glass attenuation without traction bronchiectasis and the inflammatory CT pattern, but the levels were inversely correlated with the area of ground-glass attenuation with traction bronchiectasis and the fibrotic CT pattern. The follow-up CT and serum marker changes after treatment showed that percent change of disease extent was reflected in both markers, especially KL-6. Further, the decreased fibrotic pattern correlated with both biomarkers.
CONCLUSIONS: The results indicate that serum levels of KL-6 in NSIP reflect the overall extent of interstitial lesions, which include both inflammatory and fibrotic lesions, while the levels of SP-D mainly reflect the extent of inflammatory lesions.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21555868     DOI: 10.1159/000326924

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  10 in total

1.  Elevated serum human epididymis protein 4 is associated with disease severity and worse survival in idiopathic pulmonary fibrosis: a cohort study.

Authors:  Mi Tian; Kaifang Meng; Yujuan Gao; Ji Zhang; Miaomiao Xie; Yaqiong Tian; Xiaoqin Liu; Miao Ma; Ying Cai; Hongyan Wu; Jingjing Ding; Jingyu Chen; Hourong Cai
Journal:  Ann Transl Med       Date:  2022-09

Review 2.  The molecular era of surfactant biology.

Authors:  Jeffrey A Whitsett
Journal:  Neonatology       Date:  2014-05-30       Impact factor: 4.035

3.  Carbon nanotube and nanofiber exposure and sputum and blood biomarkers of early effect among U.S. workers.

Authors:  John D Beard; Aaron Erdely; Matthew M Dahm; Marie A de Perio; M Eileen Birch; Douglas E Evans; Joseph E Fernback; Tracy Eye; Vamsi Kodali; Robert R Mercer; Stephen J Bertke; Mary K Schubauer-Berigan
Journal:  Environ Int       Date:  2018-04-23       Impact factor: 9.621

4.  Diagnostic value of KL-6 in idiopathic interstitial pneumonia.

Authors:  Peiyan Zheng; Xiaoqing Liu; Huimin Huang; Zijun Guo; Ge Wu; Haisheng Hu; Chuanxu Cai; Wenting Luo; Nili Wei; Qian Han; Baoqing Sun
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

5.  Role of serum and induced sputum surfactant protein D in predicting the response to treatment in chronic obstructive pulmonary disease.

Authors:  Wei Liu; Chun-Rong Ju; Rong-Chang Chen; Zhi-Guang Liu
Journal:  Exp Ther Med       Date:  2014-07-29       Impact factor: 2.447

6.  Factors influencing the measurement of plasma/serum surfactant protein D levels by ELISA.

Authors:  Preston E Bratcher; Amit Gaggar
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

7.  Biomarker profiles of coagulopathy and alveolar epithelial injury in acute respiratory distress syndrome with idiopathic/immune-related disease or common direct risk factors.

Authors:  Kansuke Koyama; Shinshu Katayama; Ken Tonai; Jun Shima; Toshitaka Koinuma; Shin Nunomiya
Journal:  Crit Care       Date:  2019-08-19       Impact factor: 9.097

8.  Levels of Soluble Receptor for Advanced Glycation End Products in Bronchoalveolar Lavage Fluid in Patients with Various Inflammatory Lung Diseases.

Authors:  Tetsuro Kamo; Sadatomo Tasaka; Yuriko Tokuda; Shoji Suzuki; Takanori Asakura; Kazuma Yagi; Ho Namkoong; Makoto Ishii; Naoki Hasegawa; Tomoko Betsuyaku
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2016-04-28

Review 9.  Surfactant Protein D in Respiratory and Non-Respiratory Diseases.

Authors:  Grith L Sorensen
Journal:  Front Med (Lausanne)       Date:  2018-02-08

10.  Surfactant protein D: a predictor for severity of community-acquired pneumonia in children.

Authors:  Nagwan Yossery Saleh; Reda Abdel Latif Ibrahem; Amany Abdel Hakim Saleh; Shimaa El Shafey Soliman; Asmaa Abdel Sameea Mahmoud
Journal:  Pediatr Res       Date:  2021-03-31       Impact factor: 3.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.